Last Monday, ARC Capital was involved in the Australia-China biotech invest 2017, the place to find Biotech innovators from around the world and partnership opportunities. with leading-edge technologies.

The program took place on Monday 27 March at the Marriott in Shanghai. The program featured company presentations, keynote speakers, lively panel discussions and was the perfect location for us to meet potential clients.

We discuss with the following companies in order to cooperate together:

  • Petri Exchange
  • Biotron
  • Novogen
  • FivepHusion
  • ResApp

The upcoming partnerships is an indication of ARC Capital’s capabilities to assist both public and private listed companies.